-
Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial
-
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLXT LAAC Device
-
Boston Scientific Closes Acquisition of Baylis Medical Company Inc.
-
Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
-
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
-
Acutus Medical's Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium
-
Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System
-
Medtronic to Acquire Affera
-
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
-
Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy to Treat Atrial Fibrillation
-
Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke
-
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
-
Biosense Webster Announces Completion of Atrial Fibrillation Cases Using Novel HELIOSTART Balloon Ablation Catheter
-
New Data & Innovations: Heart Rhythm 2021
-
BIOTRONIK Expands Range of Peripheral Introducer Sheaths
-
CardioFocus-Announces-Agreement-to-Acquire-Intellectual-Property-Press-Release.pdf
-
Late-Breaking Data Shows Abbott's AmplatzerT AmuletT Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman? Device for People With Atrial Fibrillation at Risk of Stroke
-
Abbott's AmplatzerT AmuletT Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
-
AcQMap 8, Acutus Medical's Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark
-
Real-World Data Demonstrate Significant Reduction in Complications and Reinterventions with Medtronic Micra Leadless Pacemaker
-
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
-
Abbott Receives European And Canadian Approval For AmplatzerT Steerable Delivery Sheath To Optimize Left Atrial Appendage Closure Procedures For People At Risk Of Stroke
-
Medtronic Receives FDA Expanded Approval for Arctic FrontT Family of Cardiac Cryoablation Catheters for Initial Use for Recurrent Symptomatic Paroxysmal Atrial Fibrillation
-
Abbott Introduces Jot DxT Insertable Cardiac Monitor, Designed To Reduce Data Burden And Improve Accurate Diagnosis Of Difficult-To-Detect Abnormal Heart Rhythms
-
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
-
New Data & Innovations: Heart Rhythm 2021
-
BIOTRONIK's Cardiac Monitor Receives Prestigious Award
-
Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLXT Left Atrial Appendage Closure Device
-
CardioFocus to Exhibit and Present Data Supporting HeartLight X3 System at Heart Rhythm 2021
-
CardioFocus Receives Regulatory Approval to Market HeartLight X3 System in Japan
-
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
-
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China
-
GE Healthcare and the American College of Cardiology Join Forces to Advance AI in Cardiac Care
-
Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes
-
Siemens Healthineers Receives CE Mark for the ACUSON AcuNav Volume ICE Catheter
-
Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial
-
Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate FORCE Sensing Ablation System
-
Japan Lifeline Finalizes Supply Agreement for Pulsed Electric Field Ablation Catheter for U.S. Market
-
Acutus Medical Announces FDA Clearance of AcQCrossT, a Full Suite of Universal Transseptal Crossing Devices
-
Acutus Medical Initiates First IDE Therapy Trial with the AcQBlate FORCE Sensing Ablation System
-
AtriCure's EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
-
Acutus Medical Receives Vizient Innovative Technology Contract
-
Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation
-
CardioFocus Announces Expanded Partnership With Japan Lifeline
-
CardioFocus Announces Expanded Distribution Partnership With MicroPortT CRM To Include Spain And Portugal
-
Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation
-
Acutus Medical Announces CE Mark and European Launch of AcQCrossT Transseptal System, a Fully Integrated Family of Transseptal Crossing Products
-
CardioFocus Announces 10,000 Patients Treated Worldwide
-
First Clinical Implantation of MicroPort Left.
-
Abbott Introduces Next-Generation 3d Cardiac Mapping Platform In Europe And Australia
-
The New England Journal of Medicine: Medtronic Cryoablation is a Superior Treatment Option for Symptomatic Paroxysmal Atrial Fibrillation Compared to Drug Therapy
-
Acutus Medical Launches AcQBlate Force Sensing Ablation System in Europe
-
Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
-
Acutus Medical Announces FDA Clearance of Second-Generation AcQMap 3D Imaging & Mapping Catheter
-
Acutus Medical Announces Pulsed Field Ablation Program and Initial Pre-Clinical Results
-
Medtronic Gains FDA Clearance, CE Mark for LINQ IIT Insertable Cardiac Monitor (ICM)
-
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
-
Stereotaxis and Acutus Medical Announce First Integrated Cardiac Ablation Procedure with TeleRobotic Support
-
Medtronic MicraT AV Receives CE Mark
-
New Alliance Maps the Way in Electrophysiology
-
CardioFocus Announces US FDA Approval of HeartLight X3 System for the Treatment of Atrial Fibrillation
-
GE Healthcare and Preventice Solutions Collaborate to Connect the Heart, the Hospital and the Home Seamlessly
-
Bristol Myers Squibb - The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
